Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1432685
PUBLISHER: KBV Research | PRODUCT CODE: 1432685
Asia Pacific Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific Pharmaceutical Suspension Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030).
The flexibility in formulation design is a key factor driving adoption. Pharmaceutical suspension allows for the customization of formulations to meet specific patient requirements. This adaptability is particularly valuable in the era of personalized medicine, where tailoring drug formulations to individual patients' needs can optimize treatment outcomes. Pediatric patients often present a unique challenge in medication administration due to taste aversion. Pharmaceutical suspensions are crucial in taste masking, making medications more palatable for children. This significantly improves medication adherence in pediatric populations, driving the adoption of suspensions in pediatric medicine.
The ease of administration associated with pharmaceutical suspensions contributes to simplified dosage regimens. This simplicity is a significant factor in patient adherence, as it reduces the likelihood of dosage errors and promotes a more consistent medication intake. The ability to control the release of drugs over an extended period is another factor contributing to adoption. Pharmaceutical suspensions enable the development of sustained-release formulations, lessening the frequency of administration and increasing patient convenience. This is particularly relevant for chronic conditions requiring long-term treatment.
As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, which is projected to reach $ 132 billion by 2023. The palatable nature of pharmaceutical suspensions can improve patient adherence in India. In a hospital setting in India, where patient compliance is crucial, the acceptability of medication formulations plays a significant role in successful treatment. Therefore, due to the above-mentioned factors, the pharmaceutical suspension market will grow significantly in this region.
The China market dominated the Asia Pacific Pharmaceutical Suspension Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,435.8 million by 2030. The Japan market is registering a CAGR of 4.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.4% during (2023 - 2030).
Based on Type, the market is segmented into Parenteral, Oral, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on End User, the market is segmented into Hospitals and Clinics, Home Care Settings, and Others. Based on Indication, the market is segmented into Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Merck & Co., Inc.
- Bayer AG
- Sanofi S.A.
- Pfizer, Inc.
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly And Company
- Lupin Limited
Asia Pacific Pharmaceutical Suspension Market Report Segmentation
By Type
- Parenteral
- Oral
- Others
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
By Indication
- Cancer
- Neurological
- Infectious Diseases
- Gastrointestinal
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Pharmaceutical Suspension Market, by Type
- 1.4.2 Asia Pacific Pharmaceutical Suspension Market, by Distribution Channel
- 1.4.3 Asia Pacific Pharmaceutical Suspension Market, by End User
- 1.4.4 Asia Pacific Pharmaceutical Suspension Market, by Indication
- 1.4.5 Asia Pacific Pharmaceutical Suspension Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter's Five Forces Analysis
Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market
Chapter 5. Asia Pacific Pharmaceutical Suspension Market by Type
- 5.1 Asia Pacific Parenteral Market by Country
- 5.2 Asia Pacific Oral Market by Country
- 5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Pharmaceutical Suspension Market by Distribution Channel
- 6.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
- 6.2 Asia Pacific Hospital Pharmacies Market by Country
- 6.3 Asia Pacific Online Providers Market by Country
Chapter 7. Asia Pacific Pharmaceutical Suspension Market by End User
- 7.1 Asia Pacific Hospitals and Clinics Market by Country
- 7.2 Asia Pacific Home Care Settings Market by Country
- 7.3 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Pharmaceutical Suspension Market by Indication
- 8.1 Asia Pacific Cancer Market by Country
- 8.2 Asia Pacific Neurological Market by Country
- 8.3 Asia Pacific Infectious Diseases Market by Country
- 8.4 Asia Pacific Gastrointestinal Market by Country
- 8.5 Asia Pacific Others Market by Country
Chapter 9. Asia Pacific Pharmaceutical Suspension Market by Country
- 9.1 China Pharmaceutical Suspension Market
- 9.1.1 China Pharmaceutical Suspension Market by Type
- 9.1.2 China Pharmaceutical Suspension Market by Distribution Channel
- 9.1.3 China Pharmaceutical Suspension Market by End User
- 9.1.4 China Pharmaceutical Suspension Market by Indication
- 9.2 Japan Pharmaceutical Suspension Market
- 9.2.1 Japan Pharmaceutical Suspension Market by Type
- 9.2.2 Japan Pharmaceutical Suspension Market by Distribution Channel
- 9.2.3 Japan Pharmaceutical Suspension Market by End User
- 9.2.4 Japan Pharmaceutical Suspension Market by Indication
- 9.3 India Pharmaceutical Suspension Market
- 9.3.1 India Pharmaceutical Suspension Market by Type
- 9.3.2 India Pharmaceutical Suspension Market by Distribution Channel
- 9.3.3 India Pharmaceutical Suspension Market by End User
- 9.3.4 India Pharmaceutical Suspension Market by Indication
- 9.4 South Korea Pharmaceutical Suspension Market
- 9.4.1 South Korea Pharmaceutical Suspension Market by Type
- 9.4.2 South Korea Pharmaceutical Suspension Market by Distribution Channel
- 9.4.3 South Korea Pharmaceutical Suspension Market by End User
- 9.4.4 South Korea Pharmaceutical Suspension Market by Indication
- 9.5 Singapore Pharmaceutical Suspension Market
- 9.5.1 Singapore Pharmaceutical Suspension Market by Type
- 9.5.2 Singapore Pharmaceutical Suspension Market by Distribution Channel
- 9.5.3 Singapore Pharmaceutical Suspension Market by End User
- 9.5.4 Singapore Pharmaceutical Suspension Market by Indication
- 9.6 Malaysia Pharmaceutical Suspension Market
- 9.6.1 Malaysia Pharmaceutical Suspension Market by Type
- 9.6.2 Malaysia Pharmaceutical Suspension Market by Distribution Channel
- 9.6.3 Malaysia Pharmaceutical Suspension Market by End User
- 9.6.4 Malaysia Pharmaceutical Suspension Market by Indication
- 9.7 Rest of Asia Pacific Pharmaceutical Suspension Market
- 9.7.1 Rest of Asia Pacific Pharmaceutical Suspension Market by Type
- 9.7.2 Rest of Asia Pacific Pharmaceutical Suspension Market by Distribution Channel
- 9.7.3 Rest of Asia Pacific Pharmaceutical Suspension Market by End User
- 9.7.4 Rest of Asia Pacific Pharmaceutical Suspension Market by Indication
Chapter 10. Company Profiles
- 10.1 Merck & Co., Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 SWOT Analysis
- 10.2 Bayer AG
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
- 10.3 Sanofi S.A.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 SWOT Analysis
- 10.4 Pfizer, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
- 10.5 Novartis AG
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 SWOT Analysis
- 10.6 AstraZeneca PLC
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
- 10.6.5.1 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
- 10.7 Glenmark Pharmaceuticals Limited
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 SWOT Analysis
- 10.8 Teva Pharmaceutical Industries Ltd.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expenses
- 10.8.5 Recent strategies and developments:
- 10.8.5.1 Product Launches and Product Expansions:
- 10.8.6 SWOT Analysis
- 10.9 Eli Lilly And Company
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
- 10.10. Lupin Limited
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
- 10.10.5.1 Partnerships, Collaborations, and Agreements:
- 10.10.5.2 Trials and Approvals:
- 10.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 2 Asia Pacific Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 3 Asia Pacific Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 4 Asia Pacific Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 5 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Million
- TABLE 6 Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Million
- TABLE 7 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
- TABLE 8 Asia Pacific Oral Market by Country, 2023 - 2030, USD Million
- TABLE 9 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 11 Asia Pacific Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 12 Asia Pacific Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 13 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 14 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 15 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 16 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 17 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
- TABLE 18 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
- TABLE 19 Asia Pacific Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 20 Asia Pacific Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 21 Asia Pacific Hospitals and Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 22 Asia Pacific Hospitals and Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 23 Asia Pacific Home Care Settings Market by Country, 2019 - 2022, USD Million
- TABLE 24 Asia Pacific Home Care Settings Market by Country, 2023 - 2030, USD Million
- TABLE 25 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 26 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 27 Asia Pacific Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 28 Asia Pacific Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 29 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
- TABLE 30 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
- TABLE 31 Asia Pacific Neurological Market by Country, 2019 - 2022, USD Million
- TABLE 32 Asia Pacific Neurological Market by Country, 2023 - 2030, USD Million
- TABLE 33 Asia Pacific Infectious Diseases Market by Country, 2019 - 2022, USD Million
- TABLE 34 Asia Pacific Infectious Diseases Market by Country, 2023 - 2030, USD Million
- TABLE 35 Asia Pacific Gastrointestinal Market by Country, 2019 - 2022, USD Million
- TABLE 36 Asia Pacific Gastrointestinal Market by Country, 2023 - 2030, USD Million
- TABLE 37 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 38 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 39 Asia Pacific Pharmaceutical Suspension Market by Country, 2019 - 2022, USD Million
- TABLE 40 Asia Pacific Pharmaceutical Suspension Market by Country, 2023 - 2030, USD Million
- TABLE 41 China Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 42 China Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 43 China Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 44 China Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 45 China Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 46 China Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 47 China Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 48 China Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 49 China Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 50 China Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 51 Japan Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 52 Japan Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 53 Japan Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 54 Japan Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 55 Japan Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 Japan Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 Japan Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 58 Japan Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 59 Japan Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 60 Japan Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 61 India Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 62 India Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 63 India Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 64 India Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 65 India Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 India Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 67 India Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 68 India Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 69 India Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 70 India Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 71 South Korea Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 72 South Korea Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 73 South Korea Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 74 South Korea Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 75 South Korea Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 76 South Korea Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 77 South Korea Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 78 South Korea Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 79 South Korea Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 80 South Korea Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 81 Singapore Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 82 Singapore Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 83 Singapore Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 84 Singapore Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 85 Singapore Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 86 Singapore Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 87 Singapore Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 88 Singapore Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 89 Singapore Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 90 Singapore Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 91 Malaysia Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 92 Malaysia Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 93 Malaysia Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 94 Malaysia Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 95 Malaysia Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 96 Malaysia Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 97 Malaysia Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 98 Malaysia Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 99 Malaysia Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 100 Malaysia Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 101 Rest of Asia Pacific Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 102 Rest of Asia Pacific Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 103 Rest of Asia Pacific Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 104 Rest of Asia Pacific Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 105 Rest of Asia Pacific Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 106 Rest of Asia Pacific Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 107 Rest of Asia Pacific Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 108 Rest of Asia Pacific Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 109 Rest of Asia Pacific Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 110 Rest of Asia Pacific Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 111 Key Information - Merck & Co., Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Sanofi S.A.
- TABLE 114 Key Information - Pfizer, Inc.
- TABLE 115 Key Information - Novartis AG
- TABLE 116 KEY INFORMATION - AstraZeneca PLC
- TABLE 117 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 118 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 119 Key Information - Eli Lilly And Company
- TABLE 120 Key Information - Lupin Limited
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.